Paul Hartmann AG (STU:PHH2) Accounts Payable: €209 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:PHH2 Paul Hartmann AG STU:PHH2
64 GF Score
Price €201.00
GF Value €226.59
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Paul Hartmann AG Accounts Payable?

Paul Hartmann AG STU:PHH2 64 Accounts Payable is €209 Mil as of Dec. 2025. GuruFocus rates STU:PHH2 with a GF Score™ of 64/100 and a GF Value™ of €226.59 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Paul Hartmann AG's Accounts Payable for the quarter that ended in Dec. 2025 was €209 Mil.

Paul Hartmann AG's quarterly Accounts Payable increased from Dec. 2024 (€241 Mil) to Jun. 2025 (€379 Mil) but then declined from Jun. 2025 (€379 Mil) to Dec. 2025 (€209 Mil).

Paul Hartmann AG's annual Accounts Payable increased from Dec. 2023 (€229 Mil) to Dec. 2024 (€241 Mil) but then declined from Dec. 2024 (€241 Mil) to Dec. 2025 (€209 Mil).

Paul Hartmann AG Accounts Payable Related Terms

Paul Hartmann AG Accounts Payable Historical Data

* Premium members only.

The historical data trend for Paul Hartmann AG's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Paul Hartmann AG Accounts Payable Chart

Paul Hartmann AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 241.83 259.46 228.91 240.82 209.36

Paul Hartmann AG Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 228.91 367.66 240.82 379.27 209.36
STU:PHH2
64GF Score
Paul Hartmann AG STU:PHH2
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Paul Hartmann AG Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of €209 Mil mean?
Paul Hartmann AG (STU:PHH2) has a Accounts Payable of €209 Mil as of Dec. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Paul Hartmann AG and its competitors.
Is Paul Hartmann AG's Accounts Payable too high?
Paul Hartmann AG's current Accounts Payable is €209 Mil. Overall, Paul Hartmann AG has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Paul Hartmann AG's Accounts Payable compare to ISRG and BDX?
Paul Hartmann AG's Accounts Payable of €209 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Devices & Instruments company?
A good Accounts Payable depends on the Medical Devices & Instruments industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Paul Hartmann AG and its competitors. Paul Hartmann AG's current Accounts Payable is €209 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paul Hartmann AG stock overvalued right now?
Based on GuruFocus' analysis, Paul Hartmann AG (STU:PHH2) is currently considered Modestly Undervalued. The stock's GF Value™ is €226.59, compared to a current price of €201.00 — trading 11.3% below its estimated fair value. The current Accounts Payable is €209 Mil. Paul Hartmann AG's overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Paul Hartmann AG (STU:PHH2), the current Accounts Payable is €209 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Paul Hartmann AG (STU:PHH2) Overvalued in 2026?

Based on GuruFocus' analysis, Paul Hartmann AG stock appears to be undervalued. The current stock price of €201.00 is trading 11.3% below its estimated GF Value™ of €226.59. GuruFocus considers Paul Hartmann AG to be Modestly Undervalued.

Key valuation signals for STU:PHH2:

  • Accounts Payable: €209 Mil
  • GF Value™: €226.59 vs. price of €201.00 (11.3% below fair value)
  • GF Score™: 64/100 with 4 warning signs

No single metric tells the full story. See the STU:PHH2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Paul Hartmann AG Business Description

Other Exchanges PHH2:Germany
Address Paul-Hartmann-Strasse 12, Heidenheim, DEU, 89522
Paul Hartmann AG engages in the production of medical and hygiene products. It operates through Wound Management, Incontinence Management and Infection Management and other segments. The Wound segment comprises wound dressing and treatment, compression therapy, first aid, immobilization, and diagnostics. The Incontinence segment provides incontinence hygiene, patient care, and medical skin care. The Infection segment consists of custom procedure trays, surgical draping systems, disposable surgical instruments, and disinfectants. The Other activities include activities in cotton-wool products, medical consumer goods and pharmaceutical products and others. All the activities are functioned through the region of US and derive revenue through the sale of medical and hygiene products.
64GF Score

Get the complete analysis for STU:PHH2

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€201.00
Price
€226.59
GF Value